- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
The House Ways & Means Committee’s markup of a closely watched health bill Wednesday (July 26) was laden with partisan frustration after Democrats accused Republicans of failing to extend price transparency requirements to Medicare Advantage and prescription drug plans, or to build up additional oversight of private equity in health care.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us